Chinnery, Patrick F
Funding for this research was provided by:
Wellcome Trust Senior Fellow in Clinical Science (101876/Z/13/Z)
UK NIHR Senior Investigator
Medical Research Council
Mitochondrial Biology Unit (MC_UP_1501/2)
Wellcome Trust Centre for Mitochondrial Research (096919Z/11/Z)
Medical Research Council (UK) Centre for Translational Muscle Disease Research (G0601943)
EU FP7 TIRCON
National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Cambridge University Hospitals NHS Foundation Trust
University of Cambridge
Article History
Received: 7 September 2015
Revised: 13 October 2015
Accepted: 14 October 2015
First Online: 26 November 2015
Conflict of interest
: The author was Chief Investigator for the Santhera Pharmaceuticals sponsored trial Rescue of Hereditary Optic Disease Outpatient Study (NCT00747487), but has remained an independent academic investigator throughout. He currently has a collaborative research project with GlaxoSmithKline on the natural history of mitochondrial disease. He has no conflict of interest with the work described in this article.